Isobolographic assessment of the effects of combinations of phenylpropanolamine and fenfluramine on food intake in rats

Paul J. Wellman, Sharon Tow, Lance McMahon

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Phenylpropanolamine (PPA) suppresses appetite in rats via activation of α1-adrenergic receptors within the paraventricular hypothalamus (PVN). The serotonergic (5-HT) agonist fenfluramine (FEN) is thought to suppress appetite via stimulation of 5-HT release within the PVN rather than activation of adrenergic receptors. Whether a mixture of these neurochemically distinct anorexic drugs will serve as an effective appetite suppressant is unknown. In the present experiment, drug-drug interactions between PPA and FEN were explored using an isobologram technique. Fixed doses of PPA (0 vs. 5 mg/kg) were combined with various doses of FEN (1.25, 2.5, and 5.0 mg/kg) and fixed doses of FEN (0 vs. 2.5 mg/kg) were combined with various doses of PPA (0, 5, 10, and 15 mg/kg). Drug combinations were injected IP 30 min before a 1-h feeding trial in 16-h food-deprived rats. PPA and FEN were dose-additive in this paradigm, an outcome that supports the feasibility of a new appetite suppressant composed of a mixture of PPA and FEN.

Original languageEnglish (US)
Pages (from-to)287-291
Number of pages5
JournalPharmacology, Biochemistry and Behavior
Volume50
Issue number2
DOIs
StatePublished - 1995
Externally publishedYes

Fingerprint

Phenylpropanolamine
Fenfluramine
Rats
Eating
Appetite Depressants
Appetite
Adrenergic Receptors
Hypothalamus
Chemical activation
Drug interactions
Serotonin Receptor Agonists
Drug Combinations
Drug Interactions
Serotonin
Food
Pharmaceutical Preparations

Keywords

  • Anorexia
  • Feeding
  • Fenfluramine
  • Paraventricular hypothalamus
  • Phenylpropanolamine
  • Serotonin
  • α-Adrenoceptors

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Behavioral Neuroscience
  • Biological Psychiatry
  • Pharmacology
  • Toxicology

Cite this

Isobolographic assessment of the effects of combinations of phenylpropanolamine and fenfluramine on food intake in rats. / Wellman, Paul J.; Tow, Sharon; McMahon, Lance.

In: Pharmacology, Biochemistry and Behavior, Vol. 50, No. 2, 1995, p. 287-291.

Research output: Contribution to journalArticle

@article{64f270858de9490aa949dfb9acd5024f,
title = "Isobolographic assessment of the effects of combinations of phenylpropanolamine and fenfluramine on food intake in rats",
abstract = "Phenylpropanolamine (PPA) suppresses appetite in rats via activation of α1-adrenergic receptors within the paraventricular hypothalamus (PVN). The serotonergic (5-HT) agonist fenfluramine (FEN) is thought to suppress appetite via stimulation of 5-HT release within the PVN rather than activation of adrenergic receptors. Whether a mixture of these neurochemically distinct anorexic drugs will serve as an effective appetite suppressant is unknown. In the present experiment, drug-drug interactions between PPA and FEN were explored using an isobologram technique. Fixed doses of PPA (0 vs. 5 mg/kg) were combined with various doses of FEN (1.25, 2.5, and 5.0 mg/kg) and fixed doses of FEN (0 vs. 2.5 mg/kg) were combined with various doses of PPA (0, 5, 10, and 15 mg/kg). Drug combinations were injected IP 30 min before a 1-h feeding trial in 16-h food-deprived rats. PPA and FEN were dose-additive in this paradigm, an outcome that supports the feasibility of a new appetite suppressant composed of a mixture of PPA and FEN.",
keywords = "Anorexia, Feeding, Fenfluramine, Paraventricular hypothalamus, Phenylpropanolamine, Serotonin, α-Adrenoceptors",
author = "Wellman, {Paul J.} and Sharon Tow and Lance McMahon",
year = "1995",
doi = "10.1016/0091-3057(94)00316-B",
language = "English (US)",
volume = "50",
pages = "287--291",
journal = "Pharmacology Biochemistry and Behavior",
issn = "0091-3057",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Isobolographic assessment of the effects of combinations of phenylpropanolamine and fenfluramine on food intake in rats

AU - Wellman, Paul J.

AU - Tow, Sharon

AU - McMahon, Lance

PY - 1995

Y1 - 1995

N2 - Phenylpropanolamine (PPA) suppresses appetite in rats via activation of α1-adrenergic receptors within the paraventricular hypothalamus (PVN). The serotonergic (5-HT) agonist fenfluramine (FEN) is thought to suppress appetite via stimulation of 5-HT release within the PVN rather than activation of adrenergic receptors. Whether a mixture of these neurochemically distinct anorexic drugs will serve as an effective appetite suppressant is unknown. In the present experiment, drug-drug interactions between PPA and FEN were explored using an isobologram technique. Fixed doses of PPA (0 vs. 5 mg/kg) were combined with various doses of FEN (1.25, 2.5, and 5.0 mg/kg) and fixed doses of FEN (0 vs. 2.5 mg/kg) were combined with various doses of PPA (0, 5, 10, and 15 mg/kg). Drug combinations were injected IP 30 min before a 1-h feeding trial in 16-h food-deprived rats. PPA and FEN were dose-additive in this paradigm, an outcome that supports the feasibility of a new appetite suppressant composed of a mixture of PPA and FEN.

AB - Phenylpropanolamine (PPA) suppresses appetite in rats via activation of α1-adrenergic receptors within the paraventricular hypothalamus (PVN). The serotonergic (5-HT) agonist fenfluramine (FEN) is thought to suppress appetite via stimulation of 5-HT release within the PVN rather than activation of adrenergic receptors. Whether a mixture of these neurochemically distinct anorexic drugs will serve as an effective appetite suppressant is unknown. In the present experiment, drug-drug interactions between PPA and FEN were explored using an isobologram technique. Fixed doses of PPA (0 vs. 5 mg/kg) were combined with various doses of FEN (1.25, 2.5, and 5.0 mg/kg) and fixed doses of FEN (0 vs. 2.5 mg/kg) were combined with various doses of PPA (0, 5, 10, and 15 mg/kg). Drug combinations were injected IP 30 min before a 1-h feeding trial in 16-h food-deprived rats. PPA and FEN were dose-additive in this paradigm, an outcome that supports the feasibility of a new appetite suppressant composed of a mixture of PPA and FEN.

KW - Anorexia

KW - Feeding

KW - Fenfluramine

KW - Paraventricular hypothalamus

KW - Phenylpropanolamine

KW - Serotonin

KW - α-Adrenoceptors

UR - http://www.scopus.com/inward/record.url?scp=0028893275&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028893275&partnerID=8YFLogxK

U2 - 10.1016/0091-3057(94)00316-B

DO - 10.1016/0091-3057(94)00316-B

M3 - Article

C2 - 7740069

AN - SCOPUS:0028893275

VL - 50

SP - 287

EP - 291

JO - Pharmacology Biochemistry and Behavior

JF - Pharmacology Biochemistry and Behavior

SN - 0091-3057

IS - 2

ER -